Seronegative naturally acquired West Nile virus encephalitis in a renal and pancreas transplant recipient

Transplant Infectious Disease

Volumn 12, Issue 5, 2010, Pages 459-464

  Koepsell, S A ^a   Freifeld, A G ^a   Sambol, A R ^b   McComb, R D ^a   Kazmi, S A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Nebraska Public Health Laboratory   (United States)

Author keywords

Diagnosis; Immunosuppression; Nucleic acid amplification testing; Renal and pancreas transplant; Serology; Transplant; West Nile virus

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; NUCLEIC ACID AMPLIFICATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; SEROLOGY; UNITED STATES; VIRUS ENCEPHALITIS; WEST NILE FLAVIVIRUS;

HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PANCREAS TRANSPLANTATION; RNA, VIRAL; WEST NILE FEVER;

EID: 78650437180     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00530.x     Document Type: Article

References (21)

1. Gubler DJ. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 2007; 45 (8): 1039-1046.
2. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358 (9278): 261-264.
3. Kumar D, Drebot MA, Wong SJ, et al. A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am J Transplant 2004; 4 (11): 1883-1888.
4. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008; 198 (7): 984-993.
5. Prince HE, Tobler LH, Lape-Nixon M, Foster GA, Stramer SL, Busch MP. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol 2005; 43 (9): 4316-4320.
6. Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 2000; 38 (11): 4066-4071.
7. Penn RG, Guarner J, Sejvar JJ, et al. Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clin Infect Dis 2006; 42 (5): 680-683.
8. Saquib R, Randall H, Chandrakantan A, Spak CW, Barri YM. West Nile virus encephalitis in a renal transplant recipient: the role of intravenous immunoglobulin. Am J Kidney Dis 2008; 52 (5): e19-e21.
9. Jain N, Fisk D, Sotir M, Kehl KS. West Nile encephalitis, status epilepticus and West Nile pneumonia in a renal transplant patient. Transpl Int 2007; 20 (9): 800-803.
10. Wadei H, Alangaden GJ, Sillix DH, et al. West Nile virus encephalitis: an emerging disease in renal transplant recipients. Clin Transplant 2004; 18 (6): 753-758.
11. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol 2004; 61 (8): 1210-1220.
12. Ravindra KV, Freifeld AG, Kalil AC, et al. West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis 2004; 38 (9): 1257-1260.
13. DeSalvo D, Roy-Chaudhury P, Peddi R, et al. West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation 2004; 77 (3): 466-469.
14. Cushing MM, Brat DJ, Mosunjac MI, et al. Fatal West Nile virus encephalitis in a renal transplant recipient. Am J Clin Pathol 2004; 121 (1): 26-31.
15. Hardinger KL, Miller B, Storch GA, Desai NM, Brennan DC. West Nile virus-associated meningoencephalitis in two chronically immunosuppressed renal transplant recipients. Am J Transplant 2003; 3 (10): 1312-1315.
16. West Nile Virus IgM Capture DxSelect Product Insert, 2007.
17. Freifeld AG, Meza J, Schweitzer B, Shafer L, Kalil AC, Sambol AR. Seroprevalence of West Nile virus infection in solid organ transplant recipients. Transpl Infect Dis 2010; 12 (2): 120-126.
18. Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med 2004; 141 (5): 360-365.
19. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med 2002; 137 (3): 173-179.
20. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47 (3): 303-327.
21. Ben-Nathan D, Gershoni-Yahalom O, Samina I, et al. Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect Dis 2009; 9: 18.